BiotechTube

famotidine (+) calcium carbonate (+) magnesium hydroxide tablet + Comparator: famotidine (+) calcium carbonate (+) magnesium hydroxide EZ Chew tablet without water + Comparator: famotidine (+) calcium carbonate (+) magnesium hydroxide EZ Chew tablet with water

Phase 1Completed
0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Heartburn

Conditions

Heartburn

Trial Timeline

Feb 1, 2008 → Mar 1, 2008

NCT ID
NCT00944671

About famotidine (+) calcium carbonate (+) magnesium hydroxide tablet + Comparator: famotidine (+) calcium carbonate (+) magnesium hydroxide EZ Chew tablet without water + Comparator: famotidine (+) calcium carbonate (+) magnesium hydroxide EZ Chew tablet with water

famotidine (+) calcium carbonate (+) magnesium hydroxide tablet + Comparator: famotidine (+) calcium carbonate (+) magnesium hydroxide EZ Chew tablet without water + Comparator: famotidine (+) calcium carbonate (+) magnesium hydroxide EZ Chew tablet with water is a phase 1 stage product being developed by Johnson & Johnson for Heartburn. The current trial status is completed. This product is registered under clinical trial identifier NCT00944671. Target conditions include Heartburn.

What happened to similar drugs?

7 of 15 similar drugs in Heartburn were approved

Approved (7) Terminated (0) Active (8)
✅esomeprazole 40 mgAstraZenecaApproved
✅Esomeprazole magnesium (Nexium)AstraZenecaApproved
✅Esomeprazole + Lansoprazole + PantoprazoleAstraZenecaApproved
✅Esomeprazole Magnesium + LansoprazoleAstraZenecaApproved
✅Esomeprazole 20 mg + PlaceboPfizerApproved
✅Talcid (Hydrotalcite, BAY4516H) + Famotidine + PlaceboBayerApproved
✅Omeprazole 20 mg + Sodium Bicarbonate 1100 mg + Omeprazole 20 mgBayerApproved

Hype Score Breakdown

Clinical
6
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT00944671Phase 1Completed

Competing Products

20 competing products in Heartburn

See all competitors
ProductCompanyStageHype Score
rabeprazole sodiumEisaiPhase 3
40
rabeprazole sodium + placeboEisaiPhase 3
40
Rabeprazole sodiumEisaiPre-clinical
26
esomeprazole 40 mgAstraZenecaApproved
43
Esomeprazole magnesium (Nexium)AstraZenecaApproved
43
EsomeprazoleAstraZenecaPhase 3
40
EsomeprazoleAstraZenecaPhase 3
40
Esomeprazole + Lansoprazole + PantoprazoleAstraZenecaApproved
43
Esomeprazole Magnesium + LansoprazoleAstraZenecaApproved
43
Famotidine FCT + Famotidine CTMerckPhase 1
29
LanzoprazoleNovartisPhase 3
40
Lansoprazole + Lansoprazole + placeboNovartisPhase 3
40
LansoprazoleNovartisPhase 3
40
TegaserodNovartisPhase 3
40
Calcium carbonate/magnesium hydroxide/Lansoprazole 15 mg + Lansoprazole + Calcium carbonate/magnesium hydroxide + PlaceboNovartisPhase 2
35
Esomeprazole 20 mg + PlaceboPfizerApproved
43
bi-layer calcium carbonate tablet (BAY1180654) + Immediate release calcium carbonate tablet (BAY1180654)BayerPhase 1
26
omeprazole/sodium bicarbonate + omeprazole magnesiumBayerPhase 1
26
Talcid (Hydrotalcite, BAY4516H) + Famotidine + PlaceboBayerApproved
40
Omeprazole 20 mg + Sodium Bicarbonate 1100 mg + Omeprazole 20 mgBayerApproved
40